The Latin America, Middle East and Africa Pain Management Devices Market is expected to witness market growth of 9.6% CAGR during the forecast period (2020-2026).
Pain management device is used to treat chronic and acute pain in patients with different conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore patients' ability to do daily activities, reduce the need for oral pain medicines, and improve the quality of life of patients suffering from these conditions.
Growing cancer cases have also resulted in increased demand for these devices to relieve pain caused by a tumor compressing one nerve and many other factors depending on the stage of cancer. The therapies are given to the patients often lead potentially to cancer pain. Studies have shown that about 20 to 50 percent of patients with cancer feel acute pain at the time of diagnosis and about 75 percent complain of pain during the development of the disease.
The major applications in the pain control equipment industry are cancer, neuropathic pain, facial pain and migraine, musculoskeletal diseases, and trauma. Neurostimulation devices play a significant role in managing neuropathic pain, as stimulators for the spinal cord deliver the best results. In addition, these devices provide benefits such as personalized stimulation rates, based on the activities that the individual undertakes in a day.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
Pain management device is used to treat chronic and acute pain in patients with different conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore patients' ability to do daily activities, reduce the need for oral pain medicines, and improve the quality of life of patients suffering from these conditions.
Growing cancer cases have also resulted in increased demand for these devices to relieve pain caused by a tumor compressing one nerve and many other factors depending on the stage of cancer. The therapies are given to the patients often lead potentially to cancer pain. Studies have shown that about 20 to 50 percent of patients with cancer feel acute pain at the time of diagnosis and about 75 percent complain of pain during the development of the disease.
The major applications in the pain control equipment industry are cancer, neuropathic pain, facial pain and migraine, musculoskeletal diseases, and trauma. Neurostimulation devices play a significant role in managing neuropathic pain, as stimulators for the spinal cord deliver the best results. In addition, these devices provide benefits such as personalized stimulation rates, based on the activities that the individual undertakes in a day.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
By Application
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Pain Management Devices Market by Product
Chapter 5. LAMEA Pain Management Devices Market by Application
Chapter 6. LAMEA Pain Management Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Methodology
LOADING...
